• HOME
  • Search & Results
  • Full Text
  • Thesis Details
 
Page: 205
 
Full Screen

  • Title
  • CERTIFICATE
  • DECLARATION
  • Thanks and Tributes
  • CONTENTS
  • I. Introduction and Review of Literature
  • Introduction
  • Review of Literature
  • CHEMICAL CARCINOGENS
  • Alkylating agents
  • Aralkylating agents
  • Arylhydroxylamines
  • GENETIC ASPECTS OF CANCER
  • Oncogenes
  • Ras gene
  • Tumour suppressor genes
  • pRB
  • p53
  • CARCINOGEN METABOLISM
  • CARCINOGENESIS AS A MULTISTAGE PROCESS
  • Initiation
  • Promotion
  • Progression
  • Malignant conversion
  • OXIDATIVE STRESS IN CHEMICAL CARCINOGENESIS
  • FREE RADICALS IN CARCINOGENECITY
  • MODIFICATION OF CARCINOGENESIS BY ANTIOXIDANTS
  • CHEMOPREVENTION
  • Ideal qualities of chemopreventative agents
  • Target populations
  • CLASSES OF CEMOPREVENTIVE AGENTS
  • Inhibitors of Carcinogen Formation
  • Blocking Agents
  • Inhibitors of cytochrome P450 enzymes
  • Inducers of Cytochrome P450 enzymes
  • Inducers phase 11 Enzymes
  • Scavengers of Electrophiles and free Radicals
  • Suppressing Agents
  • Inhibiters of Polyamine Metabolism
  • Inducers of Terminal Cell Differentiation
  • Modulators of Signal Transduction
  • Modulators of Hormonal / Growth Factor Activity
  • Inhibitors of Oncogene Activity
  • Promoters of Intercellular Communication
  • Restorers of Immune Response
  • Inducers of Apoptosis
  • Correctors of DNA Methylation Imbalances
  • Inhibitors of Basement Membrane Degradation
  • Inhibitors of Arachidonic Acid Metabolism
  • Current Human Intervention Trials
  • Phytochemicals in Chemoprevention
  • CANCER TREATMENT
  • ANTICANCER DRUGS FROM PLANTS
  • DNA Topoisomerase Targeted Drugs
  • Topoisomerase I-inhibitors
  • Topoisomerase II inhibitors
  • Microtubule-Targeting Drugs
  • Scope of the present study
  • Picrorhiza kurroa
  • Picroliv
  • Phyllanthus amarus
  • Plate: Phyllanthus amarus
  • Plate: Emblica offiinalis
  • Emblica offiinalis
  • II. Materials and Methods
  • Drugs
  • Chemicals
  • Tumour Cell lines
  • Animals
  • Determination of tumour reducing activity of plant products
  • Ascites tumour model
  • Determination of solid tumour model
  • Determination of in vitro antioxidant activity
  • Superoxide scavenging activity
  • Hydroxyl radical scavenging activity
  • Lipid peroxidation inhibition assay
  • Topoisomerase I and II inhibitory assays
  • Determination of cdc25 tyrosine phosphatase inhibitory assay
  • Estimation of protein
  • Estimation of tissue lipid peroxide
  • Estimation of serum lipid peroxide
  • Estimation of tissue superoxide dismutase (SOD) activity
  • Estimation of tissue catalase activity
  • Estimation of tissue glutathione (GSH)
  • Estimation of cytosolic glutathione-S- transferase (GST) activity
  • Estimation of Aniline Hydroxylase
  • Estimation of serum glutamate-pyruvate transaminase (GPT) activity
  • Estimation of alkaline phosphatase (ALP) activity
  • Estimation of Υ-glutamyl transpeptidase (Υ-GT) activity in tissue
  • Estimation of serum Υ-glutamyl traspeptidase (Υ-GT) activity
  • Estimation of serum bilirubin.
  • Histopathological methods
  • Hematoxylin and Eosin (H and E) staining
  • AgNOR staining
  • III. Pharmacological activity of Emblica officinalis Polyphenol
  • Section 1. Anticarcinogenic activity of Emblica officinalis polyphenol
  • 1. Introduction
  • 2. Materials and Methods
  • Preparation of polyphenolic fraction
  • Determination of in vitro antioxidant activity of EOP
  • Determination of the effect EOP on hepatocarcinogenesis induced by NDEA
  • 3. Results
  • Isolation of polyphenolic fraction
  • Antioxidant activity of EOP
  • Effect of EOP on the hepatocarcinogenesis induced by NDEA
  • 4. Discussion
  • Section 2. Induction of Apoptosis in Mouse and Human Carcinoma cell Lines by Emblica officinalis
  • 1. Introduction
  • 2. Materials and methods
  • Induction of apoptosis
  • 3. Results
  • 4. Discussion
  • Plate 2. H & E staining of DLA and CeHa cells
  • (a) DLA cells
  • (b) CeHa cells
  • (c) DLA cells treated with Emblica officinalis extract 200 &ml, show membrane blebbing and chromatin condensation
  • (d) CeHa cells treated with Emblica officinalis extract 200 pg/ml shows chromatin condensation
  • (e) DLA cells treated with EOP 200 pg/ml shows membrane blebbing
  • (f) CeHa cells treated with EOP 200 pg/ml shows chromatin condensation
  • Section 3. Antiulcerogenic activity of Emblica officinalis
  • 1. Introduction
  • 2. Materials and methods
  • Drug preparation
  • Ethanol-induced gastric ulcer
  • Indomethacin and histamine-induced gastric ulcers
  • Analytical methods
  • Histopathology
  • 3. Results
  • List of Plates
  • Plate 3. Morphology and histology of sat stomach.
  • 4.Discussion
  • IV. Pharmacological activity of Picroliv
  • Section 1. Antioxidant and Antitumour activity of Picroliv
  • 1. Introduction
  • 2. Materials and methods
  • 2.1. Determination of in vitro antioxidant activity of Picroliv
  • 2.2. Determination of the effect of Picroliv on aniline hydroxylase
  • 2.3. Determination of the effect of Picroliv on Topoisomerase I and II
  • 2.4. Determination of the effect of Picroliv on cdc25 tyrosine phosphatase.
  • 2.5. Determination of the effect of Picroliv on ascites tumour development induced by transplanted tumours
  • 2.6. Determination of the effect of Picroliv on solid tumour development induced by transplanted tumours
  • 3. Results
  • 3.1. Antioxidant activity of Picroliv
  • 3.2. Effect of Picroliv on aniline hydroxylase, topoisomerase I and II and cdc25 tyrosine phosphatase
  • 3.3. Effect of Picroliv on ascites tumour development
  • 3.4. Effect of Picroliv on solid tumour development
  • 4. Discussion
  • List of Plates
  • Plate 4. Mouse showing transplanted solid tumours, sarcomas and papillomas
  • Section 2. Anticarcinogenic activity of Picroliv
  • Effect of Picroliv on Chemical Carcinogenesis
  • 1. Introduction
  • 2. Materials and methods
  • 2.1 Determination of the effect of Picroliv administration on NDEA-induced hepatocarcinogenesis
  • 2.2 Determination of the effect of Picroliv treatment on DMH-induced toxicity
  • 2.3 Determination of the effect of Picroliv on sarcoma induced by 20-MC
  • 2.4 Determination of the effect of Picroliv treatment on papilloma formation initiated by DMBA and croton oil
  • 3. Results
  • 3.1 Effect of Picroliv treatment on NDEA induced hepatocarcinogenesis
  • 3.2 Effect of Picroliv treatment in rats administered with DMH
  • List of Plates
  • Plate 5. Gross MorphoIogy and Histopathology of rat liver
  • 3.3. Effect of Picroliv on the development of sarcomas induced by 20-MC
  • List of Plates
  • Plate 6. Histology of liver and kidney of rats
  • 3.4. Effect of Picroliv on papilloma formation induced by DMBA and croton oil
  • 4. Discussion
  • Section 3. Radioprotective and Chemoprotective activity of Picroliv
  • 1. Introduction
  • 2. Materials and methods
  • 2.1. Determination of the effect of Picroliv on mice irradiated with Cobalt 60
  • 2.2. Determination of the effect of Picroliv on cyclophosphamide-induced toxicity
  • 3. Results
  • 3.1 Effect of Picroliv on mice irradiated with Cobalt 60
  • 3.2 Effect of Picroiiv on cyclophosphamide-induced toxicity
  • 4. Discussion
  • V. Antitumor and Anticarcinogenic activity of Phyllanthus amarus and its mechanism of action
  • 1. Introduction
  • 2. Materials and methods
  • 2.1 Determination of the effect P. amarus on ascites tumours
  • 2.2 Determination of the effect P. amarus on solid tumours
  • 2.3 Determination of the effect of P. amarus extract administration during induction of hepatocarcinogenesis by NDEA
  • 2.4 Determination of the effect of P. amarus extract administration after induction of HCC by NDEA
  • 2.5 Aniline hydroxylase inhibitory assay
  • 2.6 Topoisomerase I and II inhibitory assays
  • 2.7 Determination of cdc25 tyrosine phosphatase and cdc2 kinase inhibitory assays
  • 3. Results
  • 3.1 Effect of P. amarus on ascites tumours
  • 3.2 Effect P. amarus on solid tumours
  • 3.4 Effect of simultaneous administration of P. amarus on NDEA induced hepatocarcinogenesis
  • 3.5 The effect of P. amarus extract administration after induction of HCC by NDEA
  • List of Plates
  • Plate 7. Gross morphology and histogathology of rat livers
  • 3.6 Effect of P. amarus on aniline hydroxylase
  • 3.7 Effect of P. amarus on Topoisomerase I and II
  • 3.7 The effect of P. amarus on cdc25 tyrosine phosphatase and cdc2 kinase
  • 4. Discussion
  • VI. Chemoprevention of Chemical Carcinogenesis by a Polyherbal formulation
  • 1. Introduction
  • 2. Materials and Methods
  • Preparation of Cancare
  • Determination of the effect Cancare on hepatocarcinogenesis induced by NDEA
  • Determination of the effect of Cancare on sarcoma induced by 20-MC
  • 3. Results
  • Effect of Cancare administration on NDEA induced hepatocarcinogenesis
  • Effect of Cancare administration on 20-MC induced sarcoma development
  • 4. Discussion
  • VII. Summary and Conclusion
  • References
  • Publications